{"nct_id":"NCT02303782","title":"A Study Assessing tOTX015 in Combination With Azacitidine (AZA) or AZA Single Agent in Patients With Newly-diagnosed Acute Myeloid Leukemia (AML) Not Candidate for Standard Intensive Induction Therapy (SIIT)","status":"WITHDRAWN","status_verified_date":"2016-08","start_date":"2015-01","start_date_type":null,"primary_completion_date":"2016-03","primary_completion_date_type":"ESTIMATED","completion_date":"2016-03","completion_date_type":"ESTIMATED","phases":["PHASE1","PHASE2"],"tickers":["MRK"]}